<DOC>
	<DOCNO>NCT00968409</DOCNO>
	<brief_summary>The purpose study see Positron Emission Tomography ( PET ) image radioactive form hormone progesterone call FFNP give result hormone receptor test already perform tissue use diagnose breast cancer .</brief_summary>
	<brief_title>Assessment Progesterone Receptors Breast Carcinoma Positron Emission Tomography ( PET ) Using Fluoro Furanyl Norprogesterone ( FFNP )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Female patient 18 year age old Biopsyproven breast cancer Tumor estrogenreceptor progesteronereceptor status already determine schedule determined time surgery without intervene therapy . Primary lesion size â‰¥ 1.5 cm determine image study ( ultrasonography , mammography , CT MRI ) physical examination Able give inform consent Not currently pregnant nursing : Subject must surgically sterile ( documented bilateral oophorectomy / document hysterectomy ) , post menopausal ( cessation menses 1 year ) , non lactating , childbearing potential urine pregnancy test ( test perform within 24 hour period immediately prior administration FFNP ) negative . No previous history hormone therapy ; NOTE subject treat hormone therapy reason breast cancer breast cancer prevention may allow participate review history primary investigator Patients invasive malignancy , exception nonmelanoma skin cancer , ( ) evidence cancer present within last 5 year Unable tolerate 6090 minute PET image per image session</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Hormone Receptor</keyword>
</DOC>